DNMT3A and aortic stenosis: While the prevalence of DNMT3A- and/or TET2-CHIP-driver mutations remained similar with 32.7%, the association of CHIP with mortality was even stronger in patients with severe aortic stenosis undergoing TAVR, who never smoked.